Carotid intima-media thickness in adults with and without psoriasis - a nested case-control study from baseline data of ELSA-Brasil cohort
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, v.39, n.8, p.1483-1491, 2023
Resumo
There is a lack of consensus about the association between psoriasis (PSO) and carotid intima-media thickness (cIMT) in literature, since previous studies considered dermatologic clinic patients or general population. This study aimed to compare cIMT levels according to PSO in a sample of 10,530 civil servants form the ELSA-Brasil cohort study and analyze its association with the disease. The PSO cases and disease duration were identified by medical diagnosis self-reported at study enrollment. A paired group was identified by propensity score matching among all the participants without PSO. Mean cIMT values were considered for continuous analysis while cIMT above 75th percentile was considered for categorical analysis. Multivariate conditional regression models were used to analyze association between cIMT and PSO diagnosis, by comparing PSO cases against paired controls and overall sample without disease. A total of n = 162 PSO cases were identified (1.54%) and no difference in cIMT values was observed between participants with PSO and overall sample or control group. PSO was not associated with linear increment of cIMT (vs. overall sample: beta = 0.003, p = 0.690; vs. matched controls: beta = 0.004, p = 0.633) neither with increased chance of having cIMT above 75th percentile (vs. overall sample: OR = 1.06, p = 0.777; vs. matched controls: OR = 1.19, p = 0.432; conditional regression: OR = 1.31, p = 0.254). There was no relationship between disease duration and cIMT (beta = 0.000, p = 0.627). Although no significant relationship between mild cases of psoriasis and cIMT was observed among a wide cohort of civil servants, longitudinal investigation about cIMT progression and severity of disease are still needed.
Palavras-chave
Cardiovascular risk, Intima-media thickness, Psoriasis, Nested case-control, Epidemiology
Referências
- Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
- Balci DD, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2008.02936.x
- Banska-Kisiel K, 2016, POSTEP DERM ALERGOL, V33, P286, DOI 10.5114/ada.2016.61605
- BAUER M, 2012, SWISS MED WEEKLY, V142, DOI 10.4414/SMW.2012.13705
- Bensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780
- Chor D, 2013, REV SAUDE PUBL, V47, P27, DOI 10.1590/S0034-8910.2013047003835
- Cozzani E, 2018, GIORN ITAL DERMAT V, V153, P659, DOI 10.23736/S0392-0488.18.06040-6
- Dowlatshahi EA, 2013, J INVEST DERMATOL, V133, P2347, DOI 10.1038/jid.2013.131
- Eder L, 2013, ANN RHEUM DIS, V72, P715, DOI 10.1136/annrheumdis-2012-201497
- Fang N, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003576
- Fernández-Armenteros JM, 2019, J EUR ACAD DERMATOL, V33, P128, DOI 10.1111/jdv.15159
- Gelfand JM, 2007, ARCH DERMATOL, V143, P1493, DOI 10.1001/archderm.143.12.1493
- George D., 2003, SPSS WINDOWS STEP ST, V4th ed.
- Girisha BS, 2021, INDIAN J DERMATOL VE, V87, P357, DOI 10.25259/IJDVL_214_19
- Gonzalez-Cantero A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211808
- Haberka M, 2018, POL ARCH INTERN MED, V128, P434, DOI 10.20452/pamw.4301
- Horreau C, 2013, J EUR ACAD DERMATOL, V27, P12, DOI 10.1111/jdv.12163
- Inaba Y, 2012, ATHEROSCLEROSIS, V220, P128, DOI 10.1016/j.atherosclerosis.2011.06.044
- Johnsen SH, 2007, STROKE, V38, P2873, DOI 10.1161/STROKEAHA.107.487264
- Johnsen Stein Harald, 2009, Curr Cardiol Rep, V11, P21
- Kim SY, 2015, ANGIOLOGY, V66, P889, DOI 10.1177/0003319714568790
- Lerman JB, 2017, CIRCULATION, V136, P263, DOI 10.1161/CIRCULATIONAHA.116.026859
- Masson W, 2017, MED CLIN-BARCELONA, V148, P483, DOI 10.1016/j.medcli.2016.12.011
- Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851
- Modalsli EH, 2016, J INVEST DERMATOL, V136, P323, DOI 10.1038/JID.2015.386
- Nascimento LR, 2013, REV SAUDE PUBL, V47, P113, DOI 10.1590/S0034-8910.2013047003825
- Parisi R, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1590
- Paschoal RS, 2018, METABOLIC SYNDROME C
- Patel RV, 2011, J GEN INTERN MED, V26, P1036, DOI 10.1007/s11606-011-1698-5
- Raggi P, 2020, ATHEROSCLEROSIS, V312, P119, DOI 10.1016/j.atherosclerosis.2020.09.015
- Ramos S, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.890195
- Romiti R, 2017, INT J DERMATOL, V56, pE167, DOI 10.1111/ijd.13604
- Rundek T, 2013, STROKE, V44, P2101, DOI 10.1161/STROKEAHA.111.000745
- Santos IS, 2015, ARTERIOSCL THROM VAS, V35, P2054, DOI 10.1161/ATVBAHA.115.305765
- Santos IS, 2014, ATHEROSCLEROSIS, V237, P227, DOI 10.1016/j.atherosclerosis.2014.09.004
- Santos RD, 2016, J CLIN LIPIDOL, V10, P1362, DOI 10.1016/j.jacl.2016.08.008
- Schmidt MI, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-123
- Sirtori CR, 2021, ATHEROSCLEROSIS, V317, P67, DOI 10.1016/j.atherosclerosis.2020.11.024
- Spence JD, 2020, ATHEROSCLEROSIS, V312, P117, DOI 10.1016/j.atherosclerosis.2020.09.016
- Staniak HL, 2014, ATHEROSCLEROSIS, V237, P847, DOI 10.1016/j.atherosclerosis.2014.11.004
- Tablazon ILD, 2013, AM J CLIN DERMATOL, V14, P1, DOI 10.1007/s40257-012-0005-5
- Troitzsch P, 2012, ATHEROSCLEROSIS, V225, P486, DOI 10.1016/j.atherosclerosis.2012.09.026
- Uyar B, 2015, ACTA DERMATOVENER CR, V23, P171
- Willeit P, 2020, CIRCULATION, V142, P621, DOI 10.1161/CIRCULATIONAHA.120.046361
- Lise MLZ, 2017, REV ASSOC MED BRAS, V63, P747, DOI 10.1590/1806-9282.63.09.747